Skip to main content
. 2021 Feb 12;24:65–76. doi: 10.1016/j.jor.2021.02.009

Table 2.

Demographic data of all included outcome studies on chronic Monteggia in children.

Study Number of patients Sex (M)ale, (F)emale Mean age (range) at time of surgery/*injury [in years] Mean interval injury-surgery (range) [in months] Bado Classification3 (I, II, III, IV) & Monteggia equivalents (Me)
Bor4 4 (M) 2, (F) 2 9.75 (9–11) 24 (3–56) I (4)
Kosev5 4 (M) 1, (F) 3 6.6 (4.2–9.1) 12 (2–25) I (2), III (1), Me (1)
Di Gennaro6 22 (M) 10, (F) 12 7.2 (4.1–13.6) 15.7 (1–128) I (20), III (2)
Megahed7 16 (M) 7, (F) 9 7.25 (7–12) 11.2 (3–20) I (11), II (3), III (2)
Lu8 23 (M) 16, (F) 7 6 (4–9) 7 (1.5–16) NR
Park9 22 (M) 11, (F) 11 7.6 (3.5–14.3) 16.1 (1–84) I (22)
Xu10 5 (M) 3, (F) 2 5.7 (3.4–6.8) 3 (1–4) I (5)
Ngoc Hung11 13 (M) 5, (F) 8 8.6 (6.1–12.7)/7.7 (4.7–12.5)* 12.1 (2–25) I (9), II (3), III (1)
Agarwal12 11 (M) 7, (F) 4 7.8 (6–11.5) 4 (2–11) I (6), III (2), Me (3)
Chen13 20 (M) 11, (F) 9 10.2 (3.5–16.75) 10 (1.2–49) I (18), III (2)
Eamsobhana14 30 (M) 18, (F) 12 7.4 (4–13) 23.4 (6–120) I (21), II (2), III (7)
Stragier15 14 (M) 7, (F) 7 8 (3–17) 26.9 (1–145) I (4), Me (10)
Take16 5 (M) 4, (F) 1 9 (5–14)/6,33 (2–10)* 31 (2–125) I (5)
Mazhar17 7 (M) 6, (F) 1 6.6 (4–1.8) 1.8 (1–3.5) I (4), III (2) IV (1)
He18 17 (M) 13, (F) 4 6.94 (2.08–12.58) 4.82 (0.5–25) I (16), III (1)
Wang19 13 (M) 11, (F) 2 5.66 (2.17–10) 12 (2–36) I (10), III (3)
Gallone20 20 (M) 10, (F) 10 8.1 (5.1–14.2)/6.7 (4–9.7)* 12.7 (3–38) I (19), III (1)
Liao21 33 (M) 27, (F) 6 6.9 (2–12) 7 (1–60) I (27), III (6)
Soni22 6 (M) 4, (F) 2 8.1 (3–14) 6 (1–24) I (6)
Kumar23 17 (M) 11, (F) 6 6.61 (NR) 3.52 (3–5) NR
Yuan24 11 (M) 8, (F) 3 6.5 (2–12)* 8.5 (NR) I (8), III (3)
Musikachart25 21 (M) 15, (F) 6 7.95 (5–12) 27.05 (3–120) I (21)
Çevi̇k26 18 (M) 12, (F) 6 6.9 (2.6–12.2) 2 (1–3.7) I (7), II (5), III (1), Me (5)
Total or mean† 352 (M) 219, (F) 133 7.43 years† 12.39 months I (245), II (13), III (34), IV (1), Me (19)